Twelve-Year Survival in a Patient With Systemic Sclerosis–Associated Pulmonary Arterial Hypertension on Nifedipine Monotherapy

Twelve-Year Survival in a Patient With Systemic Sclerosis–Associated Pulmonary Arterial Hypertension on Nifedipine Monotherapy

Pulmonary arterial hypertension is a progressive vascular disease with a high mortality rate without proper therapy. Identification of the appropriate treatment for each patient is critical in regard to adverse effects, health care costs, ease of treatment, and the potential for prognostication. Tre...

Full description

Bibliographic Details
Main Authors: Scott A. Helgeson, MD, Cher Y. Enderby, PharmD, RPh, John E. Moss, MD, Jennifer M. Gass, PhD, Tonya K. Zeiger, RRT, Charles D. Burger, MD
Format: Article
Language:English
Published: Elsevier 2019-09-01
Series:Mayo Clinic Proceedings: Innovations, Quality & Outcomes
Online Access:http://www.sciencedirect.com/science/article/pii/S254245481930075X

Internet

http://www.sciencedirect.com/science/article/pii/S254245481930075X

Similar Items